Cited by 4Neuropeptides and Animal PhysiologyNeuroendocrine regulation and behaviorVeterinary Pharmacology and Anesthesia

Effect of centrally administered opioid receptor agonists on CSF and plasma oxytocin concentrations in dogs

Open access
Brown, Dorothy C., Perkowski, Sandra Z., Shofer, Frances, Amico, Janet A.·2001·American Journal of Veterinary Research

Abstract

OBJECTIVE: To measure oxytocin concentrations in blood and CSF following central administration of opioid agonists in dogs. ANIMALS: 5 male dogs. PROCEDURE: In a crossover design, CSF and blood were collected immediately before and 15 and 30 minutes after cisternal administration of D-Ala2, MePhe4, Gly-ol-enkephalin (DAMGO, a mu-receptor agonist); D-Pen, pCl-Phe4, D-Pen5-enkephalin (a delta-receptor agonist); U50488H (a kappa-receptor agonist); morphine; and saline (0.9% NaCl) solution. RESULTS: Plasma oxytocin concentration was significantly increased 15 minutes after administration of DAMGO and 30 minutes after administration of U50488H, compared with concentrations obtained after administration of saline solution. Concentration of oxytocin in CSF was significantly decreased 30 minutes after administration of U50488H, compared with concentration after administration of saline solution. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that in male dogs, activation of centrally located mu and kappa receptors elicits an overall excitatory effect on neurons that regulate peripheral release of oxytocin, whereas activation of centrally located kappa receptors elicits an overall inhibitory effect on neurons that regulate central release. These results are in contrast to those reported for other species, in which opioids have a pronounced inhibitory effect on release of oxytocin from the neurohypophysis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2460/ajvr.2001.62.496

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intravenous cholecystokinin releases oxytocin into the blood and hypothalamus, but other agents affect central and peripheral release differently; in dogs, opioids stimulate peripheral secretion while suppressing central secretion.

    “In response to i.v.cholecystokinin, oxytocin is released into the blood and in the hypothalamus (79), but several other agents affect release differentially: for instance, in dogs, opioids stimulate peripheral secretion but suppress central secretion (80).”

    From Intranasal Oxytocin: Myths and Delusions (2016) · cites this paper as [80]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Hartman RD, Rosella-Dampman LM, Emmert SE, et al. Inhibition of release of neurohypophyseal hormones by endogenous opi- oid peptides in pregnant and parturient rats. Brain Res 1986;382:352-359.

Cited by

Sorted by citations

Authors
Brown, D. C., Perkowski, S. Z., Shofer, F., & Amico, J. A.
Affiliations
University of Pennsylvania (US)
Venue
American Journal of Veterinary Research
Published
2001-04-01
Volume
62
Issue
4
Pages
496-499
ISSN
0002-9645 (ISSN-L)
OpenAlex
W2055723976
Cited by
4
References
40
Citations by year
2016: 1 · 2015: 1 · 2013: 1
FWCI
0.12
Type
journal article
Language
en
Open access
Locations
  • American Journal of Veterinary Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Health Sciences › Veterinary › Small Animals › Veterinary Pharmacology and Anesthesia
Keywords
oxytocin, opioid agonists, mu-opioid receptor, kappa opioid receptor, delta opioid receptor, DAMGO, U50,488H, morphine, cerebrospinal fluid, plasma oxytocin, neurohypophysis, central nervous system, dogs
MeSH terms
Analgesics, Opioid, Animals, Dogs, Enkephalins, Injections, Spinal, Male, Morphine, Oxytocin, Random Allocation, Receptors, Opioid, Cross-Over Studies, Analgesics, Non-Narcotic, 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review